New sperm selection method tested for IVF success
NCT ID NCT05859152
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new way to select sperm for IVF. Instead of an embryologist picking the best-looking sperm, they used sperm that naturally attached to the outer layer of an immature egg. The goal was to see if this method leads to more embryos developing into blastocysts. The study involved 29 couples undergoing their first IVF cycle.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Zona Pellucida-Bound Sperm Selection for ICSI
- What this could lead to
- If this method works, it could improve embryo quality and success rates for IVF patients.
- What could go wrong
- This is a small, early-stage study with only 29 participants. The new method may not be better than the standard approach, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Reproductive Medicine Associates of Northern California
San Francisco, California, 94105, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can 'Abnormal' embryos still lead to healthy pregnancies? a new registry investigates
- Building a biological treasure trove to decode Women's health mysteries
- Can a sperm 'Quality Check' boost IVF success?
- Foam ultrasound for fertility checks: will women find it comfortable?
- A Hormone's hidden power: could progesterone be the key to unexplained infertility?
- A questionnaire to empower fertility patients — a pilot study puts it to the test